Anti-c-Myc (phospho T58) antibody [EPR17923]
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
4
(1 Review)
|
(25 Publications)
Rabbit Recombinant Monoclonal C-Myc/MYC phospho T58 antibody. Suitable for Dot, WB, ICC/IF, Flow Cyt (Intra) and reacts with Synthetic peptide, Human samples. Cited in 25 publications.
View Alternative Names
BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa cells (Human epithelial cells from cervix adenocarcinoma) labeling c-Myc (phospho T58) with ab185655 at 1/250, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 (green).
Confocal image showing nuclear staining on HeLa cells. The staining decreased after blocking with phospho peptide (100μg/ml) overnight. The control peptide is a non-phospho peptide.
The nuclear counterstain is DAPI (blue).
Tubulin is detected with Anti-alpha Tubulin antibody -Loading Control (ab7291) at 1/1000 dilution Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/500 (red).
The negative controls are as follows : -
-ve control 1 - ab185655 at 1/500 followed by ab150120 at 1/500.
-ve control 2 -ab7291 at 1/1000 followed by ab150077 at 1/500.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) treated with 200nM Calyculin A and 1uM Okadaic Acid for 60 min cells labeling c-Myc with purified ab185655 at 1/700 dilution (1 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- WB
Supplier Data
Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
Blocking and diluting buffer was 5% NFDM /TBST.
The strong band in Lane 1 of WB-2 compared to WB-1 is due to different lysate batches and a lower dilution factor (1 : 1000).
All lanes:
Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (ab185655) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 2:
HeLa (Human epithelial cell line from cervix adenocarcinoma) treated with Lambda Phosphatase whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 48 kDa
Observed band size: 57 kDa
true
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
Blocking and diluting buffer was 5% NFDM /TBST
All lanes:
Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (ab185655) at 1/5000 dilution
Lane 1:
Untreated HeLa (Human epithelial cell line from cervix adenocarcinoma ) whole cell lysate at 10 µg
Lane 2:
HeLa (Human epithelial cell line from cervix adenocarcinoma ) treated with 200nM Calyculin A and 1uM Okadaic Acid for 60 minutes whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 48 kDa
Observed band size: 57 kDa
true
Exposure time: 3min
- Dot
Lab
Dot Blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
Lane 1 : c-Myc (phospho T58).
Lane 2 : c-Myc (pT58) non-phospho peptide.
Lane 3 : c-Myc (pS62) phospho peptide.
Lane 4 : c-Myc (pS62) non-phospho peptide.
Dot blot analysis using ab185655 at a dilution of 1/1000. Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) was used as the secondary antibody at a dilution of 1/100000.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
- WB
CiteAb
Western blot - Anti-c-Myc (phospho T58) antibody [EPR17923] (AB185655)
c-Myc (phospho T58) western blot using anti-c-Myc (phospho T58) antibody [EPR17923] ab185655. Publication image and figure legend from Kazi, A., Xiang, S., et al., 2018, Nat Commun, PubMed 30514931.
ab185655 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab185655 please see the product overview.
SB blocks the phosphorylation of β-catenin S33/S37/T41 and T58 c-Myc. a Western blots of MiaPaCa2 and A549 tumor lysates from xenografts resected from mice treated with vehicle or SB. C1, C2, and C3 are tumors from mice treated with vehicle control. SB1, SB2, and SB3 are tumors from mice treated with SB. Experiment was done once. b Western blot of MiaPaCa2 and A549 cells treated with 1 µM SB for various lengths of time. Mia designates MiaPaCa2 lysates used as positive control. Experiment was done twice
false
Related conjugates and formulations (8)
-
578 PE
PE Anti-c-Myc (phospho T58) antibody [EPR17923]
-
Anti-c-Myc (phospho T58) antibody [EPR17923] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-c-Myc (phospho T58) antibody [EPR17923]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-c-Myc (phospho T58) antibody [EPR17923]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-c-Myc (phospho T58) antibody [EPR17923]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-c-Myc (phospho T58) antibody [EPR17923]
-
660 APC
APC Anti-c-Myc (phospho T58) antibody [EPR17923]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-c-Myc (phospho T58) antibody [EPR17923]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C-Myc is involved in regulating cell growth and proliferation. It forms part of the Myc/Max complex which binds to DNA to regulate gene expression. This activity affects cellular metabolism ribosome biogenesis and cell cycle entry emphasizing its regulation of cellular energy and stress response. Its expression levels critically govern normal cellular functions and homeostasis.
Pathways
C-Myc plays an important role in the cell cycle pathway and apoptosis regulation. Specifically c-Myc is associated with the Wnt signaling pathway which influences cellular proliferation and differentiation. It also interacts with other proteins like Cyclin D1 influencing cell cycle control. These interactions ensure c-Myc's involvement in regulating key processes related to cell proliferation and stability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (25)
Recent publications for all applications. Explore the full list and refine your search
Cell communication and signaling : CCS 23:162 PubMed40176110
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 84:4282-4296.e7 PubMed39454579
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 81:215 PubMed38739166
2024
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 7:541 PubMed38714838
2024
Applications
Unspecified application
Species
Unspecified reactive species
Plastic and reconstructive surgery 154:991-1001 PubMed37983882
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37762644
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 30:2213-2230 PubMed37726400
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:105083 PubMed37495110
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 21:132 PubMed36803784
2023
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 128:1005-1018 PubMed36635500
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com